Trial record 1 of 1 for:
NCT02413736
Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02413736 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 10, 2015
Last Update Posted : November 9, 2023
|
Sponsor:
Heikki Joensuu
Collaborator:
Scandinavian Sarcoma Group
Information provided by (Responsible Party):
Heikki Joensuu, Helsinki University Central Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2026 |
| Estimated Study Completion Date : | May 2033 |